Lung cancer is a leading cause of cancer mortality worldwide. In tumors, the important role
of noncoding RNA regulatory networks has been more and more reveal. EGFR has been …

Increasing evidence from epidemiological, preclinical and clinical studies suggests that
dysregulated inflammatory response plays a pivotal role in a multitude of chronic ailments …

Evidence has emerged in the last two decades that at the molecular level most chronic
diseases, including cancer, are caused by a dysregulated inflammatory response. The …

Celecoxib is a paradigmatic selective inhibitor of cyclooxygenase-2 (COX-2). This anti-
inflammatory drug has potent anti-tumor activity in a wide variety of human epithelial tumor …

Results of preclinical studies suggesting that the efficacy of molecular therapies is enhanced
when they are combined with radiation have generated a surge of clinical trials combining …

Objective To evaluate the prognostic influence of adenocarcinoma (AC) and
adenosquamous carcinoma (ASC) in patients with FIGO stage IB–IIA cervical cancer who …

Radiotherapy (RT) is considered as a standard in the treatment of most solid cancers,
including glioblastoma, lung, breast, rectal, prostate, colorectal, cervical, esophageal, and …

The expression of Ki67, BCL-2, and COX-2 was investigated in 53 canine cutaneous mast
cell tumors (MCTs) by immunohistochemistry and quantitative real time polymerase chain …

The most important prognostic variables of cervical carcinoma are FIGO stage, lymph node
status and clinical-pathological features of primary tumor. Recently, there has been …

AIMS: The prediction of sensitivity and resistance to neoadjuvant therapy has great potential
value for many tumour sites. A neoadjuvant regimen is increasingly the gold standard in …